A sophisticated process of synthesis

Leader Biomedical’s OssGro^® line is produced with MBCP™ Technology, a method producing biphasic bone substitutes closely resembling natural bone, for optimal bone regeneration. Unlike other bulk production methodologies, this method relies on a controlled process of synthesis, sublimation, and sintering.

Regeneration

• The specific combination of 60% HA and 40% βTCP results in a highly regulated resorption rate
• Release of Ca2+ and PO43- ions promote controlled bone regeneration

Porosity

• Macroporous structure proven ideal for cell colonisation and improved osteoconductivity
• Microporous structure ensures interstitial fluids flow freely to enable growth factors to reach cells

Permeability

• The fully permeable network of interconnected pores absorbs three times the graft’s weight in fluids, like bone marrow, in under two minutes

Safety

• No risk of residual chemical or organic material

Availability

• No natural limit on availability